The Impact of COVID-19 Vaccination on Symptoms of Anxiety and Depression before and after COVID-19 Vaccines Were Universally Available for Adults in the United States
Depression and Anxiety · 2024
DOI: 10.1155/2024/9682710 ↗Kurz gefasst
Fachartikel in der Zeitschrift Depression and Anxiety, 2024. Verfasst von Angela M Parcesepe und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternal and Child Health, Gillings School of Public Health, University of North Carolina, 427 Rosenau Hall, CB #7445, Chapel Hill, NC …. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Anxiety, COVID-19, Depression. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIMH NIH HHS, NIAID NIH HHS.
Themen: Depression
Abstract (Originalsprache)
Our objective was to examine the influence of COVID-19 vaccination on recent (i.e., past month) moderate or severe symptoms of anxiety ( GAD ‐ 7 ≥ 10 ) or depression ( PHQ ‐ 8 ≥ 10 ) before and after the COVID-19 vaccine became universally available for adults in the U.S. Participants belonged to the Communities, Households, and SARS-CoV-2 Epidemiology Cohort (CHASING COVID), a national longitudinal study. Our analytic population included 4,832 participants who reported vaccination status from December 2020 to December 2021 with follow-up outcomes assessed through March 2022. We emulated a hypothetical randomized experiment, a target trial, to estimate the effect of COVID-19 vaccination on symptoms of anxiety or depression. Before vaccines were universally available, participants who were vaccinated versus not had significantly lower adjusted odds of symptoms of moderate or severe anxiety (aOR: 0.79; 95% CI: 0.70-0.89). In the universal vaccine era, vaccination was associated with marginally higher adjusted odds of symptoms of moderate or severe anxiety (aOR: 1.23; 95% CI: 1.00-1.50). Vaccination did not influence subsequent moderate or severe depressive symptoms in the preuniversal vaccine era (aOR: 0.92; 95% CI: 0.82-1.03) or universal vaccine era (aOR: 1.11; 95% CI: 0.91-1.36). Research into the longitudinal relationship between COVID-19 vaccination and symptoms of depression and anxiety is warranted, with a focus on advancing understanding of potential mediators on the pathway between vaccination and mental health as well as modifiable factors, such as vaccine hesitancy or vaccine beliefs, that may help identify populations for whom vaccination may be particularly beneficial to their mental health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Maternal and Child Health, Gillings School of Public Health, University of North Carolina, 427 Rosenau Hall, CB #7445, Chapel Hill, NC 27599-7445, USA.
- Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.
- Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, NY, USA.
- Emergency Preparedness Research Evaluation and Practice (EPREP) Program, Harvard T.H. Chan School of Public Health, 90 Smith St, Boston, MA 02120, USA.
- Department of Community Health and Social Sciences, Graduate School of Public Health and Health Policy, City University of New York (CUNY), 55 W 125th St, New York, NY 10027, USA.
ORCID-Profile: Angela M Parcesepe, Rebecca Zimba, Amanda Berry
Förderung
- NICHD NIH HHS
- NIMH NIH HHS
- NIAID NIH HHS
- National Institute of Child Health and Human Development
- Center for Lesbian and Gay Studies, University of New York city
- Pfizer
- National Institute of Mental Health
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Parcesepe, A. M., Nash, D., Shen, J., Kulkarni, S. G., Zimba, R., You, W., Berry, A., Piltch-Loeb, R., Fleary, S. A., Stanton, E., Grov, C., & Robertson, M. M. (2024). The Impact of COVID-19 Vaccination on Symptoms of Anxiety and Depression before and after COVID-19 Vaccines Were Universally Available for Adults in the United States. Depression and Anxiety. https://doi.org/10.1155/2024/9682710
Vancouver
Parcesepe AM, Nash D, Shen J, Kulkarni SG, Zimba R, You W, et al. The Impact of COVID-19 Vaccination on Symptoms of Anxiety and Depression before and after COVID-19 Vaccines Were Universally Available for Adults in the United States. Depression and Anxiety. 2024. doi:10.1155/2024/9682710
BibTeX
@article{Parcesepe2024,
author = {Parcesepe, Angela M and Nash, Denis and Shen, Jenny and Kulkarni, Sarah G and Zimba, Rebecca and You, William and Berry, Amanda and Piltch-Loeb, Rachael and Fleary, Sasha A and Stanton, Eva and Grov, Christian and Robertson, McKaylee M},
title = {The Impact of COVID-19 Vaccination on Symptoms of Anxiety and Depression before and after COVID-19 Vaccines Were Universally Available for Adults in the United States},
journal = {Depression and Anxiety},
year = {2024},
doi = {10.1155/2024/9682710}
}
EUVIMED